SIBONI, SIMONA MARIA
SIBONI, SIMONA MARIA
DIPARTIMENTO DI MEDICINA INTERNA (attivo dal 01/01/1998 al 27/04/2012)
Type 2M/2A von Willebrand disease: a shared phenotype between type 2M and 2A
2024 O. Seidizadeh, L. Mollica, S. Zambarbieri, L. Baronciani, A. Cairo, P. Colpani, G. Cozzi, M.T. Pagliari, A. Ciavarella, S.M. Siboni, F. Peyvandi
Emicizumab in Type 3 von Willebrand Disease: Report of a Case with an Alloantibody and Literature Review
2024 A.C. Giuffrida, S.M. Siboni, L. Baronciani, G. Poli, G. Gandini, F. Peyvandi
Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database
2024 S. Mohsenian, R. Palla, M. Menegatti, A. Cairo, A. Lecchi, A. Casini, M. Neerman-Arbez, R. Asselta, S. Scardo, S.M. Siboni, J. Blatny, O. Zapletal, J. Schved, M. Giansily-Blaizot, S. Halimeh, M.A. Daoud, H. Platokouki, H. Pergantou, R.E.G. Schutgens, M. Van Haaften-Spoor, P. Brons, B. Laros-van Gorkom, E. Van Pinxten, M. Borhany, N. Fatima, D. Mikovic, M. Saracevic, G.N. Özdemir, Y. Ay, M. Makris, C. Lockley, A. Mumford, A. Harvey, S. Austin, A. Shapiro, A. Williamson, C. Mcguinn, I. Goldberg, P. De Moerloose, F. Peyvandi
Assessing joint health in haemophilia patients: The combined value of physical examination and ultrasound imaging
2024 R. Gualtierotti, A. Giachi, A. Truma, S. Arcudi, A. Ciavarella, P. Bucciarelli, D. Consonni, E. Boccalandro, V. Begnozzi, L.P. Solimeno, S.M. Siboni, F. Peyvandi
Variant p.Tyr1584Cys: a frequent von Willebrand factor variant in search of von Willebrand disease
2024 O. Seidizadeh, L. Baronciani, P. Colpani, G. Cozzi, A. Ciavarella, S.M. Siboni, F. Peyvandi
Safety and efficacy of combined dual antiplatelet therapy and factor VIII prophylaxis in patients with haemophilia A after acute coronary syndrome
2024 P. Agosti, S.M. Siboni, A. Ciavarella, S. Arcudi, F. Boggio, R. Gualtierotti, F. Peyvandi
Anti-emicizumab antibodies do not cross-react with mim8 in vitro
2023 C. Valsecchi, R. Gualtierotti, S. Arcudi, A. Ciavarella, S.M. Siboni, L. Schiavone, M. Beeg, M. Gobbi, F. Peyvandi
Genetic determinants of enhanced von Willebrand factor clearance from plasma
2023 O. Seidizadeh, L. Baronciani, M.T. Pagliari, G. Cozzi, P. Colpani, A. Cairo, S.M. Siboni, E. Biguzzi, F. Peyvandi
Updates on Novel Non-Replacement Drugs for Hemophilia
2022 R. Gualtierotti, S. Pasca, A. Ciavarella, S. Arcudi, A. Giachi, I. Garagiola, C. Suffritti, S.M. Siboni, F. Peyvandi
The dominant p.Thr274Pro mutation in the von Willebrand factor propeptide causes the von Willebrand disease type 1 phenotype in two unrelated patients
2022 M.T. Pagliari, L. Baronciani, C. Cordiglieri, P. Colpani, G. Cozzi, S.M. Siboni, F. Peyvandi
Increasing levels of von Willebrand factor and factor VIII with age in patients affected by von Willebrand disease : REPLY from original authors Biguzzi et al
2021 E. Biguzzi, S.M. Siboni, S. le Cessie, L. Baronciani, F.R. Rosendaal, A. van Hylckama Vlieg, F. Peyvandi
X Chromosome inactivation: a modifier of factor VIII and IX plasma levels and bleeding phenotype in Haemophilia carriers
2020 I. Garagiola, M. Mortarino, S.M. Siboni, M. Boscarino, M.E. Mancuso, M. Biganzoli, E. Santagostino, F. Peyvandi
Acquired Von Willebrand syndrome and response to desmopressin
2018 E. Biguzzi, S.M. Siboni, F. Peyvandi
Current challenges in the diagnosis and management of patients with inherited von Willebrand's disease in Italy: An Expert Meeting Report on the diagnosis and surgical and secondary long-term prophylaxis
2018 P. Schinco, G. Castaman, A. Coppola, D. Cultrera, C. Ettorre, A.C. Giuffrida, E. Marchesini, R. Marino, M. Milan, C. Molinari, S.M. Siboni, E. Zanon, A.B. Federici
Differential diagnosis between type 2A and 2B von Willebrand disease in a child with a previously undescribed de novo mutation
2018 M.T. Pagliari, L. Baronciani, F. Stufano, P. Colpani, S.M. Siboni, F. Payvandi
Establishment of a bleeding score as a diagnostic tool for patients with rare bleeding disorders
2016 R. Palla, S.M. Siboni, M. Menegatti, K.M. Musallam, F. Peyvandi
Factor XIII deficiency : preliminary results of the PRO-RBDD project
2015 F. Peyvandi, R. Palla, M. Menegatti, S. Siboni, M. Boscarino, B. Lachmann, S. Halimeh, N. Fatima, M. Borhany, N. Ozdemir, M. Saracevic, D. Mikovic, A. Harvey, A. Mumford, F. Hsu, J. Chapin, H. Pergantou, H. Platokouki, A. Yilmaz, A. Williamson, A. Shapiro, A. Casini, P. de Moerloose, J. Payne, L. Muszbek
Inherited bleeding disorders in pregnancy : rare coagulation factor defects
2015 M. Menegatti, F. Peyvandi, S. Siboni
Management of orthopaedic surgery in rare bleeding disorders
2014 S.M. Siboni, E. Biguzzi, G. Pasta, P.M. Mannucci, C. Mistretta, N.N. Fantini, L.P. Solimeno, F. Peyvandi
Salvage therapy with high dose Intravenous Immunoglobulins in acquired Von Willebrand Syndrome and unresponsive severe intestinal bleeding
2014 M. Cugno, A. Tedeschi, S.M. Siboni, F. Stufano, F. Depetri, F.M. Franchi, S. Griffini, F. Peyvandi